2 recruiting, 1 active not recruiting, 1 not yet recruiting, 1 terminated. 6 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Recruiting 2, Active not recruiting 1, Not yet recruiting 1, Terminated 1, Unknown 1 |
Follow palbociclib: new trials by email Literature Review of palbociclib trials Research Report on palbociclib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment Ribociclib; abemaciclib; palbociclib; Dalpiciclib - Breast Cancer Stage III, Breast Cancer Stage II | Not applicable | Not yet recruiting | Hongmei Zheng, PhD | 40 | 2025-04-01 | 2025-03-17 |
| A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer Sirolimus (albumin - bound), Palbociclib, Fulvestrant - Advanced HR - Positive, HER2 - Negative Breast Cancer, Resistant to (Neo)Adjuvant Endocrine Therapy | Not applicable | Recruiting | Fudan University | 36 | 2025-02-28 | 2025-03-04 |
| Backline Treatment of Advanced Hepatocellular Carcinoma With Palbociclib Palbociclib capsules - Hepatocellular Carcinoma | Not applicable | Recruiting | Henan Cancer Hospital | 22 | 2024-01-15 | 2024-06-27 |
| Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study Trametinib, Cobimetinib, Binimetinib - Cancer | Not applicable | Terminated | Peter MacCallum Cancer Centre, Australia | 3 | 2021-09-23 | 2023-05-10 |
| Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients Palbociclib, locoregional treatment - Breast Cancer Stage IV, Radiotherapy | Not applicable | Active not recruiting | UNICANCER | 200 | 2019-10-23 | 2026-05-20 |
| The Combination of Palbociclib With ddEC-P as Neoadjuvant Therapy in Triple Negative Breast Cancer Palbociclib, Placebo oral capsule, Epirubicin - Breast Cancer, Breast Diseases | Not applicable | Unknown | Zhejiang Cancer Hospital | 100 | 2018-12-01 | 2018-12-07 |
Breast Neoplasms (3) · Breast Diseases (1) · Carcinoma, Hepatocellular (1) · Neoplasms (1)
Fudan University (1) · Henan Cancer Hospital (1) · Hongmei Zheng, PhD (1) · Peter MacCallum Cancer Centre, Australia (1) · UNICANCER (1) · Zhejiang Cancer Hospital (1)
China (2) · Australia (1) · France (1)
Claire Bonneau, MD (1) · Ding Xiaowen, DR. (1) · Hao Zhuang, M.D. (1) · Stephen Luen, MBBS (1)